Colrain Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-113,896
| Closed | -$3.78M | – | 60 |
|
|
2017
Q2 | $3.78M | Sell |
113,896
-34,950
| -23% | -$1.16M | 1.54% | 29 |
|
|
2017
Q1 | $4.78M | Sell |
148,846
-100,304
| -40% | -$3.22M | 1.44% | 27 |
|
|
2016
Q4 | $9.03M | Sell |
249,150
-110,100
| -31% | -$3.99M | 1.89% | 21 |
|
|
2016
Q3 | $16.5M | Sell |
359,250
-44,325
| -11% | -$2.04M | 3.73% | 4 |
|
|
2016
Q2 | $20.3M | Sell |
403,575
-17,750
| -4% | -$892K | 4.04% | 3 |
|
|
2016
Q1 | $22.5M | Sell |
421,325
-139,175
| -25% | -$7.45M | 3.92% | 3 |
|
|
2015
Q4 | $36.8M | Buy |
560,500
+143,100
| +34% | +$9.39M | 3.73% | 7 |
|
|
2015
Q3 | $23.6M | Buy |
+417,400
| New | +$23.6M | 2.46% | 21 |
|
|
2015
Q1 | – | Sell |
-6,000
| Closed | -$345K | – | 103 |
|
|
2014
Q4 | $345K | Sell |
6,000
-9,000
| -60% | -$518K | 0.03% | 81 |
|
|
2014
Q3 | $806K | Sell |
15,000
-2,500
| -14% | -$134K | 0.06% | 75 |
|
|
2014
Q2 | $917K | Buy |
17,500
+2,500
| +17% | +$131K | 0.07% | 78 |
|
|
2014
Q1 | $793K | Sell |
15,000
-17,500
| -54% | -$925K | 0.06% | 76 |
|
|
2013
Q4 | $1.3M | Buy |
32,500
+18,500
| +132% | +$742K | 0.09% | 72 |
|
|
2013
Q3 | $529K | Sell |
14,000
-13,500
| -49% | -$510K | 0.04% | 82 |
|
|
2013
Q2 | $1.08M | Buy |
+27,500
| New | +$1.08M | 0.08% | 74 |
|